Portal hypertension

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Boehringer Ingelheim International GmbH Commercial
    BI 685509
    2023-504257-12-00 9 countries 2022 n=62
    Ended
  • Boehringer Ingelheim International GmbH Commercial
    BI 685509
    2023-506083-13-00 5 countries 2024 n=22
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Boehringer Ingelheim International GmbH Commercial 2 Phase II 0
New trials by year
2022
1
2024
1
← All indication landscapes